Press release
Global Gene Therapy Market Size, Status and Forecast 2018-2025 | Bluebird Bio, Sangamo, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio
visionresearchreports.com adds “Global Gene Therapy Market Size, Status and Forecast 2018-2025” new report to its research database.
This report focuses on the global Gene Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gene Therapy development in United States, Europe and China.
Gene therapy is an experimental treatment that involves introducing genetic material into a persons cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a vector. The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.
Gene therapy is a method that involves introducing genetic material into a persons cells to fight or prevent diseases. In recent decades of years, researchers are paying more and more attention on it. Until today, it is still in infancy. There are many bio-technology companies entered into this market and carry on related research and development.
Get Sample Copy Of This Report @ https://www.visionresearchreports.com/report/sample/1039
These research companies are including Bluebird Bio, Sangamom, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical and Advantagene. Among them, the top 5 research companies occupied more than 85% market.
Generally, the research fees of companies are come from their collaboration partners. For example, Bayer Healthcare is the partner of Dimension Therapeutics. General, some products of these companies are in the period 3 of their pipeline.
In general, cancer diseases are still the largest application with market share over 65% in 2015. In addition, there are some companies are focus on rare diseases.
In 2017, the global Gene Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
The key players covered in this study
Bluebird Bio
Sangamo
Spark Therapeutics
Dimension Therapeutics
Avalanche Bio
Celladon
Vical Inc.
Advantagene
Market segment by Type, the product can be split into
Ex vivo
In Vivo
Market segment by Application, split into
Cancer
Monogenic
Infectious disease
Cardiovascular disease
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Gene Therapy status, future forecast, growth opportunity, key market and key players.
To present the Gene Therapy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Gene Therapy are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
View Complete Report @ https://www.visionresearchreports.com/global-gene-therapy-market-size-status-and-forecast-2018-2025/1039
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Gene Therapy Market Size Growth Rate by Type (2013-2025)
1.4.2 Ex vivo
1.4.3 In Vivo
1.5 Market by Application
1.5.1 Global Gene Therapy Market Share by Application (2013-2025)
1.5.2 Cancer
1.5.3 Monogenic
1.5.4 Infectious disease
1.5.5 Cardiovascular disease
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Gene Therapy Market Size
2.2 Gene Therapy Growth Trends by Regions
2.2.1 Gene Therapy Market Size by Regions (2013-2025)
2.2.2 Gene Therapy Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Gene Therapy Market Size by Manufacturers
3.1.1 Global Gene Therapy Revenue by Manufacturers (2013-2018)
3.1.2 Global Gene Therapy Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.2 Gene Therapy Key Players Head office and Area Served
3.3 Key Players Gene Therapy Product/Solution/Service
3.4 Date of Enter into Gene Therapy Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Gene Therapy Market Size by Type (2013-2018)
4.2 Global Gene Therapy Market Size by Application (2013-2018)
5 United States
5.1 United States Gene Therapy Market Size (2013-2018)
5.2 Gene Therapy Key Players in United States
5.3 United States Gene Therapy Market Size by Type
5.4 United States Gene Therapy Market Size by Application
6 Europe
6.1 Europe Gene Therapy Market Size (2013-2018)
6.2 Gene Therapy Key Players in Europe
6.3 Europe Gene Therapy Market Size by Type
6.4 Europe Gene Therapy Market Size by Application
7 China
7.1 China Gene Therapy Market Size (2013-2018)
7.2 Gene Therapy Key Players in China
7.3 China Gene Therapy Market Size by Type
7.4 China Gene Therapy Market Size by Application
8 Japan
8.1 Japan Gene Therapy Market Size (2013-2018)
8.2 Gene Therapy Key Players in Japan
8.3 Japan Gene Therapy Market Size by Type
8.4 Japan Gene Therapy Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Gene Therapy Market Size (2013-2018)
9.2 Gene Therapy Key Players in Southeast Asia
9.3 Southeast Asia Gene Therapy Market Size by Type
9.4 Southeast Asia Gene Therapy Market Size by Application
10 India
10.1 India Gene Therapy Market Size (2013-2018)
10.2 Gene Therapy Key Players in India
10.3 India Gene Therapy Market Size by Type
10.4 India Gene Therapy Market Size by Application
11 Central & South America
11.1 Central & South America Gene Therapy Market Size (2013-2018)
11.2 Gene Therapy Key Players in Central & South America
11.3 Central & South America Gene Therapy Market Size by Type
11.4 Central & South America Gene Therapy Market Size by Application
12 International Players Profiles
12.1 Bluebird Bio
12.1.1 Bluebird Bio Company Details
12.1.2 Company Description and Business Overview
12.1.3 Gene Therapy Introduction
12.1.4 Bluebird Bio Revenue in Gene Therapy Business (2013-2018)
12.1.5 Bluebird Bio Recent Development
12.2 Sangamo
12.2.1 Sangamo Company Details
12.2.2 Company Description and Business Overview
12.2.3 Gene Therapy Introduction
12.2.4 Sangamo Revenue in Gene Therapy Business (2013-2018)
12.2.5 Sangamo Recent Development
12.3 Spark Therapeutics
12.3.1 Spark Therapeutics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Gene Therapy Introduction
12.3.4 Spark Therapeutics Revenue in Gene Therapy Business (2013-2018)
12.3.5 Spark Therapeutics Recent Development
12.4 Dimension Therapeutics
12.4.1 Dimension Therapeutics Company Details
12.4.2 Company Description and Business Overview
12.4.3 Gene Therapy Introduction
12.4.4 Dimension Therapeutics Revenue in Gene Therapy Business (2013-2018)
12.4.5 Dimension Therapeutics Recent Development
12.5 Avalanche Bio
12.5.1 Avalanche Bio Company Details
12.5.2 Company Description and Business Overview
12.5.3 Gene Therapy Introduction
12.5.4 Avalanche Bio Revenue in Gene Therapy Business (2013-2018)
12.5.5 Avalanche Bio Recent Development
12.6 Celladon
12.6.1 Celladon Company Details
12.6.2 Company Description and Business Overview
12.6.3 Gene Therapy Introduction
12.6.4 Celladon Revenue in Gene Therapy Business (2013-2018)
12.6.5 Celladon Recent Development
12.7 Vical Inc.
12.7.1 Vical Inc. Company Details
12.7.2 Company Description and Business Overview
12.7.3 Gene Therapy Introduction
12.7.4 Vical Inc. Revenue in Gene Therapy Business (2013-2018)
12.7.5 Vical Inc. Recent Development
12.8 Advantagene
12.8.1 Advantagene Company Details
12.8.2 Company Description and Business Overview
12.8.3 Gene Therapy Introduction
12.8.4 Advantagene Revenue in Gene Therapy Business (2013-2018)
12.8.5 Advantagene Recent Development
13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Request To Buy This Premium Report @ https://www.visionresearchreports.com/report/cart/1039
About Us
Vision Research Reports is unquestionably an expert in providing research reports on a diverse number of subjects including Alternative and Green Energy, Chemical, Energy, Glass, Machinery, Manufacturing, and Pharmaceuticals and Materials. We cater to distinguished MNCs, private equity firms, SMEs and Chinese companies pertaining to their market research data requirements.
Contact Us
Sai Krupa
Office no.1,
shivneri nagar,
kondhwa Khurd, Pune 411048
This report focuses on the global Gene Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gene Therapy development in United States, Europe and China.
Gene therapy is an experimental treatment that involves introducing genetic material into a persons cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a vector. The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.
Gene therapy is a method that involves introducing genetic material into a persons cells to fight or prevent diseases. In recent decades of years, researchers are paying more and more attention on it. Until today, it is still in infancy. There are many bio-technology companies entered into this market and carry on related research and development.
Get Sample Copy Of This Report @ https://www.visionresearchreports.com/report/sample/1039
These research companies are including Bluebird Bio, Sangamom, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical and Advantagene. Among them, the top 5 research companies occupied more than 85% market.
Generally, the research fees of companies are come from their collaboration partners. For example, Bayer Healthcare is the partner of Dimension Therapeutics. General, some products of these companies are in the period 3 of their pipeline.
In general, cancer diseases are still the largest application with market share over 65% in 2015. In addition, there are some companies are focus on rare diseases.
In 2017, the global Gene Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
The key players covered in this study
Bluebird Bio
Sangamo
Spark Therapeutics
Dimension Therapeutics
Avalanche Bio
Celladon
Vical Inc.
Advantagene
Market segment by Type, the product can be split into
Ex vivo
In Vivo
Market segment by Application, split into
Cancer
Monogenic
Infectious disease
Cardiovascular disease
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Gene Therapy status, future forecast, growth opportunity, key market and key players.
To present the Gene Therapy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Gene Therapy are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
View Complete Report @ https://www.visionresearchreports.com/global-gene-therapy-market-size-status-and-forecast-2018-2025/1039
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Gene Therapy Market Size Growth Rate by Type (2013-2025)
1.4.2 Ex vivo
1.4.3 In Vivo
1.5 Market by Application
1.5.1 Global Gene Therapy Market Share by Application (2013-2025)
1.5.2 Cancer
1.5.3 Monogenic
1.5.4 Infectious disease
1.5.5 Cardiovascular disease
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Gene Therapy Market Size
2.2 Gene Therapy Growth Trends by Regions
2.2.1 Gene Therapy Market Size by Regions (2013-2025)
2.2.2 Gene Therapy Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Gene Therapy Market Size by Manufacturers
3.1.1 Global Gene Therapy Revenue by Manufacturers (2013-2018)
3.1.2 Global Gene Therapy Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.2 Gene Therapy Key Players Head office and Area Served
3.3 Key Players Gene Therapy Product/Solution/Service
3.4 Date of Enter into Gene Therapy Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Gene Therapy Market Size by Type (2013-2018)
4.2 Global Gene Therapy Market Size by Application (2013-2018)
5 United States
5.1 United States Gene Therapy Market Size (2013-2018)
5.2 Gene Therapy Key Players in United States
5.3 United States Gene Therapy Market Size by Type
5.4 United States Gene Therapy Market Size by Application
6 Europe
6.1 Europe Gene Therapy Market Size (2013-2018)
6.2 Gene Therapy Key Players in Europe
6.3 Europe Gene Therapy Market Size by Type
6.4 Europe Gene Therapy Market Size by Application
7 China
7.1 China Gene Therapy Market Size (2013-2018)
7.2 Gene Therapy Key Players in China
7.3 China Gene Therapy Market Size by Type
7.4 China Gene Therapy Market Size by Application
8 Japan
8.1 Japan Gene Therapy Market Size (2013-2018)
8.2 Gene Therapy Key Players in Japan
8.3 Japan Gene Therapy Market Size by Type
8.4 Japan Gene Therapy Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Gene Therapy Market Size (2013-2018)
9.2 Gene Therapy Key Players in Southeast Asia
9.3 Southeast Asia Gene Therapy Market Size by Type
9.4 Southeast Asia Gene Therapy Market Size by Application
10 India
10.1 India Gene Therapy Market Size (2013-2018)
10.2 Gene Therapy Key Players in India
10.3 India Gene Therapy Market Size by Type
10.4 India Gene Therapy Market Size by Application
11 Central & South America
11.1 Central & South America Gene Therapy Market Size (2013-2018)
11.2 Gene Therapy Key Players in Central & South America
11.3 Central & South America Gene Therapy Market Size by Type
11.4 Central & South America Gene Therapy Market Size by Application
12 International Players Profiles
12.1 Bluebird Bio
12.1.1 Bluebird Bio Company Details
12.1.2 Company Description and Business Overview
12.1.3 Gene Therapy Introduction
12.1.4 Bluebird Bio Revenue in Gene Therapy Business (2013-2018)
12.1.5 Bluebird Bio Recent Development
12.2 Sangamo
12.2.1 Sangamo Company Details
12.2.2 Company Description and Business Overview
12.2.3 Gene Therapy Introduction
12.2.4 Sangamo Revenue in Gene Therapy Business (2013-2018)
12.2.5 Sangamo Recent Development
12.3 Spark Therapeutics
12.3.1 Spark Therapeutics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Gene Therapy Introduction
12.3.4 Spark Therapeutics Revenue in Gene Therapy Business (2013-2018)
12.3.5 Spark Therapeutics Recent Development
12.4 Dimension Therapeutics
12.4.1 Dimension Therapeutics Company Details
12.4.2 Company Description and Business Overview
12.4.3 Gene Therapy Introduction
12.4.4 Dimension Therapeutics Revenue in Gene Therapy Business (2013-2018)
12.4.5 Dimension Therapeutics Recent Development
12.5 Avalanche Bio
12.5.1 Avalanche Bio Company Details
12.5.2 Company Description and Business Overview
12.5.3 Gene Therapy Introduction
12.5.4 Avalanche Bio Revenue in Gene Therapy Business (2013-2018)
12.5.5 Avalanche Bio Recent Development
12.6 Celladon
12.6.1 Celladon Company Details
12.6.2 Company Description and Business Overview
12.6.3 Gene Therapy Introduction
12.6.4 Celladon Revenue in Gene Therapy Business (2013-2018)
12.6.5 Celladon Recent Development
12.7 Vical Inc.
12.7.1 Vical Inc. Company Details
12.7.2 Company Description and Business Overview
12.7.3 Gene Therapy Introduction
12.7.4 Vical Inc. Revenue in Gene Therapy Business (2013-2018)
12.7.5 Vical Inc. Recent Development
12.8 Advantagene
12.8.1 Advantagene Company Details
12.8.2 Company Description and Business Overview
12.8.3 Gene Therapy Introduction
12.8.4 Advantagene Revenue in Gene Therapy Business (2013-2018)
12.8.5 Advantagene Recent Development
13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Request To Buy This Premium Report @ https://www.visionresearchreports.com/report/cart/1039
About Us
Vision Research Reports is unquestionably an expert in providing research reports on a diverse number of subjects including Alternative and Green Energy, Chemical, Energy, Glass, Machinery, Manufacturing, and Pharmaceuticals and Materials. We cater to distinguished MNCs, private equity firms, SMEs and Chinese companies pertaining to their market research data requirements.
Contact Us
Sai Krupa
Office no.1,
shivneri nagar,
kondhwa Khurd, Pune 411048
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
